Reuters logo
BRIEF-Biostage receives FDA orphan drug designation for Cellspan Esophageal Implant
December 1, 2016 / 12:10 PM / a year ago

BRIEF-Biostage receives FDA orphan drug designation for Cellspan Esophageal Implant

Dec 1 (Reuters) - Biostage Inc :

* Biostage receives FDA orphan drug designation for cellspan esophageal implant Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below